EvoNext Holdings SA ELVAF Stock
EvoNext Holdings SA Price Chart
EvoNext Holdings SA ELVAF Financial and Trading Overview
| EvoNext Holdings SA stock price | 1.1 USD |
| Previous Close | 4.76 USD |
| Open | 4.76 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 4.76 - 4.76 USD |
| 52 Week Range | 0.001 - 15.9 USD |
| Volume | 6 USD |
| Avg. Volume | 14 USD |
| Market Cap | 24.79M USD |
| Beta (5Y Monthly) | 0.506813 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.15 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ELVAF Valuation Measures
| Enterprise Value | 31.18M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.5949986 |
| Price/Book (mrq) | 0.2001682 |
| Enterprise Value/Revenue | 2.007 |
| Enterprise Value/EBITDA | -1.882 |
Trading Information
EvoNext Holdings SA Stock Price History
| Beta (5Y Monthly) | 0.506813 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 15.9 USD |
| 52 Week Low | 0.001 USD |
| 50-Day Moving Average | 5.74 USD |
| 200-Day Moving Average | 3.29 USD |
ELVAF Share Statistics
| Avg. Volume (3 month) | 14 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 5.21M |
| Float | 4.42M |
| Short Ratio | N/A |
| % Held by Insiders | 10.70% |
| % Held by Institutions | 21.20% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -279.074% |
| Operating Margin (ttm) | -140.11% |
| Gross Margin | -9.96% |
| EBITDA Margin | -106.61% |
Management Effectiveness
| Return on Assets (ttm) | -9.47% |
| Return on Equity (ttm) | -36.44% |
Income Statement
| Revenue (ttm) | 15.54M USD |
| Revenue Per Share (ttm) | 3.63 USD |
| Quarterly Revenue Growth (yoy) | 111.40% |
| Gross Profit (ttm) | -1549200 USD |
| EBITDA | -16568000 USD |
| Net Income Avi to Common (ttm) | -43366400 USD |
| Diluted EPS (ttm) | -11.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.14M USD |
| Total Cash Per Share (mrq) | 1.15 USD |
| Total Debt (mrq) | 15.06M USD |
| Total Debt/Equity (mrq) | 14.17 USD |
| Current Ratio (mrq) | 1.614 |
| Book Value Per Share (mrq) | 23.78 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18880700 USD |
| Levered Free Cash Flow (ttm) | -10899125 USD |
Profile of EvoNext Holdings SA
| Country | United States |
| State | N/A |
| City | Reinach |
| Address | Duggingerstrasse 23 |
| ZIP | 4153 |
| Phone | 41 61 485 2000 |
| Website | https://www.evolva.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 50 |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Q&A For EvoNext Holdings SA Stock
What is a current ELVAF stock price?
EvoNext Holdings SA ELVAF stock price today per share is 1.1 USD.
How to purchase EvoNext Holdings SA stock?
You can buy ELVAF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EvoNext Holdings SA?
The stock symbol or ticker of EvoNext Holdings SA is ELVAF.
Which industry does the EvoNext Holdings SA company belong to?
The EvoNext Holdings SA industry is Biotechnology.
How many shares does EvoNext Holdings SA have in circulation?
The max supply of EvoNext Holdings SA shares is 10.89M.
What is EvoNext Holdings SA Price to Earnings Ratio (PE Ratio)?
EvoNext Holdings SA PE Ratio is now.
What was EvoNext Holdings SA earnings per share over the trailing 12 months (TTM)?
EvoNext Holdings SA EPS is -0.15 USD over the trailing 12 months.
Which sector does the EvoNext Holdings SA company belong to?
The EvoNext Holdings SA sector is Healthcare.